29 patents
Page 2 of 2
Utility
Gene Therapies for Lysosomal Disorders
30 Sep 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa ABELIOVICH, Laura HECKMAN, Herve RHINN
Filed: 17 Jun 20
Utility
Gene Therapies for Lysosomal Disorders
9 Sep 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 5 Apr 20
Utility
Gene Therapies for Neurodegenerative Diseases
9 Sep 20
The disclosure relates, in some aspects, to compositions and methods for treatment of neurodegenerative diseases (e.g., amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD), Alzheimer's disease, Gaucher disease, Parkinson's disease, Lewy body dementia, or a lysosomal storage disease).
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 23 Apr 20
Utility
Gene Therapies for Lysosomal Disorders
2 Sep 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 2 Oct 18
Utility
Gene Therapies for Lysosomal Disorders
22 Jul 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa ABELIOVICH, Laura HECKMAN, Herve RHINN
Filed: 2 Oct 18
Utility
Gene Therapies for Lysosomal Disorders
22 Jul 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa ABELIOVICH, Laura HECKMAN, Herve RHINN
Filed: 2 Oct 18
Utility
Gene therapies for lysosomal disorders
22 Jun 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 20 Nov 19
Utility
Gene Therapies for Lysosomal Disorders
4 Mar 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa ABELIOVICH, Laura Heckman, Herve Rhinn
Filed: 20 Nov 19
Utility
Gene Therapies for Lysosomal Disorders
4 Mar 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa ABELIOVICH, Laura Heckman, Herve Rhinn
Filed: 19 Nov 19